Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases. | Sci Transl Med | 2023 | 37134154 | PubTator, text mining | PubMed |
| The Genomic Landscape of Vulvar Squamous Cell Carcinoma. | Int J Gynecol Pathol | 2023 | 37131274 | PubTator, text mining | PubMed |
| H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma. | Respir Res | 2023 | 37131252 | PubTator, text mining | PubMed |
| Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma. | Front Oncol | 2023 | 37124542 | PubTator, text mining | PubMed |
| Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients. | Sci Rep | 2023 | 37120674 | PubTator, text mining | PubMed |
| Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing. | Pathologica | 2023 | 37114627 | PubTator, text mining | PubMed |
| Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer. | Cancer Res Treat | 2023 | 37114476 | PubTator, text mining | PubMed |
| An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. | Genes (Basel) | 2023 | 37107631 | PubTator, text mining | PubMed |
| Single duplex DNA sequencing with CODEC detects mutations with high sensitivity. | Nat Genet | 2023 | 37106072 | PubTator, text mining | PubMed |
| Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer. | Nat Commun | 2023 | 37105962 | PubTator, text mining | PubMed |
| Evaluation of in vitro and in vivo personalized cancer treatment assays for oral squamous cell carcinoma. | Transl Oncol | 2023 | 37099957 | PubTator, text mining | PubMed |
| Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. | J Inflamm Res | 2023 | 37092128 | PubTator, text mining | PubMed |
| Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma. | Front Oncol | 2023 | 37091151 | PubTator, text mining | PubMed |
| Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. | Expert Rev Hematol | 2023 | 37086394 | PubTator, text mining | PubMed |
| Epigenetic moonlighting: Catalytic-independent functions of histone modifiers in regulating transcription. | Sci Adv | 2023 | 37083523 | PubTator, text mining | PubMed |
| Inferring early genetic progression in cancers with unobtainable premalignant disease. | Nat Cancer | 2023 | 37081260 | PubTator, text mining | PubMed |
| Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathology. | Nat Commun | 2023 | 37080969 | PubTator, text mining | PubMed |
| Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer. | Front Oncol | 2023 | 37077822 | PubTator, text mining | PubMed |
| RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription. | Sci Adv | 2023 | 37075125 | PubTator, text mining | PubMed |
| A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma. | Front Genet | 2023 | 37065485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=34